Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,689-8,700 of 23,847
Drug study icon
CompletedNCT06225115

Safety study of KYN-5356 in Schizophrenia

This study is completed in the United States. It is testing KYN-5356 for Schizophrenia.

In Glendale
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Kynexis B.V.
Condition
Schizophrenia
Drug study icon
CompletedNCT01819818

A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients

This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In KyungKi
SchizophreniaDrug
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Drug study icon
CompletedNCT06280235

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

Multiple locations, including Tucson
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Belgium, Bulgaria, ...
Sponsor
Boehringer Ingelheim
Condition
Depression
Drug study icon
CompletedNCT03893825

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication TV-46000 can better prevent setbacks and support longer-term stability.

Multiple locations, including Phoenix
SchizophreniaDrugFrom 13 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.